You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

LIQUAEMIN SODIUM PRESERVATIVE FREE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Liquaemin Sodium Preservative Free patents expire, and what generic alternatives are available?

Liquaemin Sodium Preservative Free is a drug marketed by Aspen Global Inc and is included in one NDA.

The generic ingredient in LIQUAEMIN SODIUM PRESERVATIVE FREE is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Liquaemin Sodium Preservative Free

A generic version of LIQUAEMIN SODIUM PRESERVATIVE FREE was approved as heparin sodium by HOSPIRA on April 28th, 1983.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LIQUAEMIN SODIUM PRESERVATIVE FREE?
  • What are the global sales for LIQUAEMIN SODIUM PRESERVATIVE FREE?
  • What is Average Wholesale Price for LIQUAEMIN SODIUM PRESERVATIVE FREE?
Summary for LIQUAEMIN SODIUM PRESERVATIVE FREE
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:LIQUAEMIN SODIUM PRESERVATIVE FREE at DailyMed
Drug patent expirations by year for LIQUAEMIN SODIUM PRESERVATIVE FREE

US Patents and Regulatory Information for LIQUAEMIN SODIUM PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aspen Global Inc LIQUAEMIN SODIUM PRESERVATIVE FREE heparin sodium INJECTABLE;INJECTION 000552-011 Apr 11, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Aspen Global Inc LIQUAEMIN SODIUM PRESERVATIVE FREE heparin sodium INJECTABLE;INJECTION 000552-012 Apr 11, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Aspen Global Inc LIQUAEMIN SODIUM PRESERVATIVE FREE heparin sodium INJECTABLE;INJECTION 000552-013 Apr 11, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

LIQUAEMIN SODIUM PRESERVATIVE FREE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Liquaemin Sodium Preservative Free

Overview of Liquaemin Sodium Preservative Free

Liquaemin Sodium, also known as heparin sodium, is a type of anticoagulant used to prevent and treat blood clots in various medical conditions, including pulmonary embolism and deep vein thrombosis. The preservative-free version of this medication is particularly important for patients who may be sensitive to preservatives or have specific medical conditions that require the avoidance of such additives[5].

Market Demand and Drivers

Increasing Need for Anticoagulants

The demand for anticoagulants like Liquaemin Sodium Preservative Free is driven by the rising incidence of thrombotic disorders. Conditions such as deep vein thrombosis, pulmonary embolism, and atrial fibrillation are becoming more prevalent, especially among the aging population. This increase in incidence directly translates to a higher demand for effective anticoagulant treatments[1].

Growing Geriatric Population

The global population is aging, and older adults are more susceptible to thrombotic events. This demographic shift is expected to drive the demand for anticoagulants, including Liquaemin Sodium Preservative Free, as healthcare providers seek to manage and prevent blood clots in this vulnerable population[3].

Advances in Healthcare Infrastructure

Improvements in healthcare infrastructure, particularly in developing nations, enhance access to diagnosis and treatment. This expansion in healthcare services is likely to increase the market for anticoagulants as more patients are diagnosed and treated for thrombotic conditions[3].

Regulatory Environment

Regulatory changes and approvals can significantly impact the market dynamics of pharmaceuticals. For Liquaemin Sodium Preservative Free, any modifications in regulations related to medication approvals, pricing, and safety standards can influence its market trajectory. For instance, stricter safety regulations might increase the demand for preservative-free versions of the drug[3].

Financial Trajectory

Current Market Size

While specific financial data for Liquaemin Sodium Preservative Free is not readily available, the broader anticoagulant market provides a context. The anticoagulant market is substantial and growing, driven by the increasing need for blood clot prevention and treatment.

Projected Growth

The market for anticoagulants is expected to grow due to the factors mentioned above. For example, the overall anticoagulant market is projected to see significant growth as the incidence of thrombotic disorders increases and healthcare infrastructure improves. This growth trend is likely to benefit Liquaemin Sodium Preservative Free as well.

Cost-Effectiveness

The cost-effectiveness of anticoagulant treatments is a critical factor in their adoption. Liquaemin Sodium Preservative Free, being a well-established anticoagulant, is likely to remain competitive in terms of pricing. However, the introduction of generic versions of heparin sodium could impact the market dynamics by offering more affordable alternatives, potentially affecting the financial trajectory of the preservative-free version[1].

Competitive Landscape

Generic Versions

The introduction of generic versions of heparin sodium can significantly impact the market for Liquaemin Sodium Preservative Free. Generic versions make the medication more accessible and affordable, which can lead to increased market competition. However, the preservative-free version may still maintain a niche market due to its specific benefits for certain patient groups[3].

Brand Loyalty and Trust

Liquaemin Sodium Preservative Free benefits from brand recognition and trust built over years of use. Healthcare providers and patients often prefer established brands due to their proven efficacy and safety profiles, which can help maintain market share despite competition from generics[5].

Side Effects and Safety Considerations

Bleeding Risks

One of the significant concerns with anticoagulants like Liquaemin Sodium Preservative Free is the risk of bleeding. This risk is particularly heightened in older adults, especially women over 60 years of age. Managing these risks through careful patient monitoring and dose adjustment is crucial for maintaining market confidence in the drug[5].

Salt Content

The sodium content in Liquaemin Sodium Preservative Free is another safety consideration, especially for patients on a salt-restricted diet or those with conditions like heart failure. This aspect must be carefully managed to avoid adverse effects and maintain the drug's safety profile[5].

Regulatory and Compliance Issues

FDA Approvals and Guidelines

Regulatory approvals and guidelines play a vital role in the market dynamics of pharmaceuticals. For Liquaemin Sodium Preservative Free, compliance with FDA regulations regarding safety, efficacy, and manufacturing standards is essential. Any changes in these regulations can impact the drug's market position[1].

International Standards

Compliance with international standards and regulations is also crucial. The drug must meet the approval criteria in various global regions to be marketed and sold, which can affect its financial trajectory and market reach[1].

Patient and Healthcare Provider Preferences

Preference for Preservative-Free Options

There is a growing preference among healthcare providers and patients for preservative-free medications, especially for long-term use or in sensitive patient populations. This preference can drive the demand for Liquaemin Sodium Preservative Free, even in the face of generic competition[4].

Ease of Administration

The ease of administration and the availability of different dosage forms (e.g., intravenous, subcutaneous) can influence patient and healthcare provider preferences. Liquaemin Sodium Preservative Free, with its various administration options, can maintain a strong market position based on these factors[5].

Key Takeaways

  • Increasing Demand: The demand for anticoagulants like Liquaemin Sodium Preservative Free is driven by the rising incidence of thrombotic disorders and an aging population.
  • Regulatory Impact: Changes in regulatory environments can significantly affect the market dynamics and financial trajectory of the drug.
  • Generic Competition: The introduction of generic versions of heparin sodium can impact the market, but the preservative-free version may maintain a niche market.
  • Safety Considerations: Managing bleeding risks and salt content is crucial for maintaining market confidence.
  • Patient Preferences: There is a growing preference for preservative-free medications, which can drive demand.

FAQs

What is Liquaemin Sodium Preservative Free used for?

Liquaemin Sodium Preservative Free is used to prevent and treat blood clots in various medical conditions, including pulmonary embolism and deep vein thrombosis.

What are the main side effects of Liquaemin Sodium Preservative Free?

The main side effects include bleeding risks, which are particularly heightened in older adults, and concerns related to its sodium content.

How does the introduction of generic versions affect the market for Liquaemin Sodium Preservative Free?

The introduction of generic versions can increase market competition, but the preservative-free version may still maintain a niche market due to its specific benefits.

What regulatory factors impact the market for Liquaemin Sodium Preservative Free?

Regulatory approvals, guidelines, and changes in regulations regarding safety, efficacy, and manufacturing standards can significantly impact the market dynamics.

Why is there a preference for preservative-free medications like Liquaemin Sodium Preservative Free?

There is a growing preference for preservative-free medications, especially for long-term use or in sensitive patient populations, due to the potential for fewer adverse reactions.

Sources

  1. DrugBank Online: Heparin: Uses, Interactions, Mechanism of Action.
  2. Science.gov: Creatine Kinase CK-MB.
  3. Verified Market Research: Oxcarbazepine Drug Market Size & Forecast.
  4. PharmaCompass: Liquaemin sodium preservative free.
  5. WebMD: Liquaemin Sodium Solution - Uses, Side Effects, and More.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.